患有门性高血压的儿童的免疫特征
Fabiola Di Dato1, Raffaele Iorio2, Eirini Kyrana3
1Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy; The Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, King's College London, London, UK.
概括
儿童的门高血压存在诊断和治疗方面的挑战. 研究强调了免疫系统的作用.
科学领域:
- 儿科胃肠病学和肝病学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 门高血压是一种严重的临床综合征,并发症严重.
- 目前的诊断方法,如肝静脉压梯度测量是侵入性的,治疗选择是有限的,往往需要在儿童肝脏移植.
- 免疫系统,炎症和血管变化在门高血压病原发生的相互作用尚未完全理解.
研究的目的:
- 审查当前关于免疫因素在门高血压发展和进展中的作用的知识.
- 探索免疫反应,肝脏变化和儿科患者的门性高血压之间的联系.
- 识别潜在的非侵入性诊断标记物和治疗点.
主要方法:
- 关于细胞因子,免疫细胞和分子机制的当前研究的文献综述.
- 分析免疫系统对炎症和血管重塑在门高血压的影响.
- 综合关于儿科门高血压的诊断和治疗挑战的信息.
主要成果:
- 细胞因子,免疫细胞和其他分子显著促进炎症和血管变化在门高血压.
- 免疫系统在肝脏变化的发展和进展中起着至关重要的作用,与门性高血压有关.
- 目前的理解表明,免疫失调和门高血压病原之间存在强烈的相互作用.
结论:
- 对免疫系统参与的更深入的理解对于推进门性高血压研究至关重要.
- 识别儿童诊断和并发症预测的非侵入性标志物是未来的关键方向.
- 免疫调节策略可能为儿童门性高血压的管理提供新的治疗途径.
相关概念视频
Hepatic Portal System
5.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174


